SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUERRINI, Remo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.364
AS - Asia 16.672
EU - Europa 9.508
SA - Sud America 2.629
AF - Africa 362
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 16
Totale 63.580
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.779
SG - Singapore 6.442
CN - Cina 4.149
BR - Brasile 2.016
DE - Germania 1.859
VN - Vietnam 1.810
UA - Ucraina 1.707
IT - Italia 1.583
HK - Hong Kong 1.432
GB - Regno Unito 1.069
TR - Turchia 969
FI - Finlandia 760
FR - Francia 617
SE - Svezia 467
RU - Federazione Russa 427
JP - Giappone 377
PL - Polonia 366
IN - India 317
CA - Canada 287
BD - Bangladesh 235
MX - Messico 225
AR - Argentina 199
ID - Indonesia 174
ZA - Sudafrica 137
NL - Olanda 125
IQ - Iraq 123
BE - Belgio 106
PK - Pakistan 105
CO - Colombia 97
EC - Ecuador 97
ES - Italia 86
PH - Filippine 74
SA - Arabia Saudita 61
LT - Lituania 60
AT - Austria 58
UZ - Uzbekistan 58
VE - Venezuela 57
MA - Marocco 52
MY - Malesia 51
CL - Cile 48
PY - Paraguay 42
TN - Tunisia 37
AE - Emirati Arabi Uniti 32
IE - Irlanda 32
CZ - Repubblica Ceca 31
JO - Giordania 31
KR - Corea 31
IR - Iran 30
PE - Perù 27
EG - Egitto 25
KE - Kenya 25
UY - Uruguay 24
IL - Israele 22
NO - Norvegia 21
AL - Albania 19
AZ - Azerbaigian 19
DZ - Algeria 18
AU - Australia 17
LB - Libano 17
NP - Nepal 17
RO - Romania 17
BO - Bolivia 16
ET - Etiopia 16
CH - Svizzera 15
TH - Thailandia 12
GR - Grecia 11
KZ - Kazakistan 11
BG - Bulgaria 10
JM - Giamaica 10
NZ - Nuova Zelanda 10
PT - Portogallo 10
SN - Senegal 10
TW - Taiwan 10
BH - Bahrain 9
HN - Honduras 9
PA - Panama 9
DO - Repubblica Dominicana 8
EU - Europa 8
NI - Nicaragua 8
LV - Lettonia 7
MD - Moldavia 7
NG - Nigeria 7
KG - Kirghizistan 6
OM - Oman 6
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
CI - Costa d'Avorio 5
GE - Georgia 5
GT - Guatemala 5
HR - Croazia 5
HU - Ungheria 5
RS - Serbia 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BJ - Benin 4
DK - Danimarca 4
GY - Guiana 4
KH - Cambogia 4
LY - Libia 4
Totale 63.496
Salva come PNG Salva come JPEG
Città #
Singapore 4.043
Ashburn 3.848
Fairfield 3.528
Woodbridge 3.260
Houston 2.136
San Jose 1.869
Jacksonville 1.844
Ann Arbor 1.682
Chandler 1.529
Seattle 1.421
Hong Kong 1.405
Beijing 1.303
Santa Clara 1.272
Wilmington 1.259
Cambridge 1.191
Ho Chi Minh City 648
Izmir 546
Munich 546
Nanjing 493
Dallas 479
Los Angeles 478
Ferrara 457
New York 411
Princeton 405
Hanoi 391
Lauterbourg 357
Tokyo 352
Warsaw 316
San Diego 311
Boardman 307
Helsinki 273
Milan 265
São Paulo 215
Falkenstein 195
Shanghai 191
Shenyang 154
Hefei 153
Nanchang 153
Dearborn 146
Council Bluffs 138
London 133
Mexico City 132
Falls Church 125
Turku 123
Tianjin 117
San Mateo 114
Orem 112
The Dalles 106
Jakarta 100
Frankfurt am Main 98
Brussels 97
Jiaxing 96
Brooklyn 92
Buffalo 91
Moscow 89
Da Nang 86
Chicago 85
Addison 84
Hebei 84
Changsha 82
Johannesburg 82
Atlanta 81
Mountain View 81
Montreal 77
Redwood City 77
Haiphong 75
Bremen 74
Porto Alegre 74
Bologna 73
Norwalk 73
Toronto 70
Denver 68
San Francisco 68
Rio de Janeiro 67
Stockholm 64
Jinan 62
Washington 61
Philadelphia 55
Chennai 54
Guangzhou 54
Zhengzhou 53
Auburn Hills 51
Phoenix 50
Tashkent 50
Belo Horizonte 48
Boston 45
Columbus 45
Kunming 45
Poplar 45
Baghdad 43
Manchester 42
Amsterdam 39
Biên Hòa 39
Lahore 39
Brasília 38
Dhaka 37
Medellín 36
Curitiba 35
Montréal 35
Ningbo 35
Totale 44.256
Salva come PNG Salva come JPEG
Nome #
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 392
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 389
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 335
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 324
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 291
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 287
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 286
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 283
AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions 274
A new selective antagonist of the nociceptin receptor 269
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 269
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 258
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 257
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 253
A new ligand for the urotensin II receptor 252
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 251
Designing artificial metalloenzymes exploiting the Spy technology: study of a Cu(II)-Spy construct and perspectives 246
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 242
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 240
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 239
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 237
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 237
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 236
Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity 236
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor 235
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 234
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 234
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 233
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 232
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 231
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 230
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 228
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 227
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 226
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 226
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 225
Zn(II) and Ni(II) complexes with poly-histidyl peptides derived from a snake venom 225
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 222
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 222
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 222
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 222
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 221
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 219
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 218
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 217
[Nphe(1),Arg(14),Lys(15)]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray 217
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 217
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 214
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 212
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 212
Pharmacological characterization of tachykinin tetrabranched derivatives 212
[Nphe(1)]-Nociceptin (1-13)-NH2, a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats 211
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 211
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 211
Physicochemical stability of cabazitaxel and docetaxel solutions 210
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 209
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 209
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 209
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 206
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 206
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 206
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 204
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 203
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex 201
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 201
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 201
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 200
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 199
Neuropeptide S receptor ligands: a patent review (2005-2016) 199
Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease 199
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 198
Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505). 198
Pharmacological characterization of nociceptin receptor: an in vitro study 198
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 197
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 196
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 196
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 196
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 196
Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release 196
Copper-ion interaction with the 106-113 domain of the prion protein: a solution-equilibria study on model peptides 195
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 195
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 194
Structure-activity study at positions 3 and 4 of human neuropeptide S. 194
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 193
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 193
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 193
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 192
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 190
Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task. 189
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 189
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 188
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 188
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 188
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 188
Design of d-opioid peptide antagonists for emerging drug applications 187
Novel Aryl Sulfonamide Derivatives as NLRP3 Inflammasome Inhibitors for the Potential Treatment of Cancer 185
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 185
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 185
Anxiolytic-like effect of neuropeptide S in the rat defensive burying 184
Bioinorganic chemistry of calcitermin-the picklock of its antimicrobial activity 184
Totale 22.261
Salva come PNG Salva come JPEG
Categoria #
all - tutte 278.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.372
Totale 281.811
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.655 0 0 0 0 0 0 0 0 0 700 649 306
2021/20224.133 164 406 403 268 268 173 239 266 143 316 321 1.166
2022/20233.859 417 165 123 473 635 534 194 379 543 21 225 150
2023/20241.915 224 248 114 49 110 296 73 176 41 39 62 483
2024/20258.352 213 185 726 258 995 735 244 608 1.350 842 1.163 1.033
2025/202622.121 2.381 982 2.120 3.012 3.186 1.538 2.855 1.293 2.178 2.576 0 0
Totale 64.168